FDA
approval
· 2023-05-31
FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
FDA approved a supplemental application for Naloxone hydrochloride from Hospira, a generic opioid antagonist.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)